HF
ISPC icon

HRT Financial’s iSpecimen ISPC Stock Holding History

HRT Financial’s Portfolio ISPC Stock Details ISPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-57
Closed -$14K – 2770
2024
Q2 		$14K Buy
+57
New +$13.7K ﹤0.01% 1971
2023
Q4 		– Sell
-17
Closed -$8K – 2690
2023
Q3 		$8K Buy
+17
New +$15K ﹤0.01% 2142

Other funds holding ISPC

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HRT Financial's ISPC Position: Q3 2024 in Review

HRT Financial sold out of iSpecimen (ISPC) in Q3 2024, closing a stake of 57 shares — an estimated $14K sold.

HRT Financial first reported a position in ISPC in Q3 2023 and held it in 2 quarters. The position peaked at $14K in Q2 2024. 6 funds tracked by Wall St. Rank hold ISPC as of Q3 2024.

  • HRT Financial reported no remaining iSpecimen position as of Q3 2024 after selling out during the quarter.
  • HRT Financial sold 57 iSpecimen shares in Q3 2024, an estimated $14K.
  • HRT Financial first reported a position in iSpecimen in Q3 2023 and held it in 2 quarters.
  • HRT Financial's iSpecimen position peaked at $14K in Q2 2024.
  • 6 funds tracked by Wall St. Rank held iSpecimen as of Q3 2024.

Based on HRT Financial's 13F filing for Q3 2024, filed 12 Nov 2024.